Crinetics Pharmaceuticals (CRNX) EBIT Margin Growth (5y) (2022 - 2025)

Crinetics Pharmaceuticals (CRNX) EBIT Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,930.72 Bn 1,930.66 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 471.36 Bn 466.57 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.47 Bn 116.22 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.28 Bn 61.52 Bn 3.31 Bn
7 Belite Bio 62.00 Bn 62.00 Bn -
8 Argenx Se 56.08 Bn 50.89 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn
10 Crinetics Pharmaceuticals 8.72 Bn 7.43 Bn 10.53 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.29 Mn
Mar 31, 2025 -581,504.00
Mar 31, 2024 -875,212.00
Sep 30, 2023 -1.56 Mn
Jun 30, 2023 -449,887.00
Mar 31, 2023 -54,067.00
Dec 31, 2022 -623,380.00
Sep 30, 2022 -911,684.00
Jun 30, 2022 -960,776.00